What is the official ID of this bill?

The official print number for this legislation is HR 4096.

When did the legislative process begin?

The process officially started on 2023-06-14.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr4096/BILLS-118hr4096ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Who is the primary sponsor?

The primary sponsor is Rep. Carter, Earl L. "Buddy" [R-GA-1].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 4096

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Expanding Antipsychotic Drug Monitoring to All Medicaid Recipients.

Q: What are the main provisions?

Key points include: Effective January 1, 2024, state Medicaid programs must monitor the use of antipsychotic medications for all beneficiaries, regardless of age. This expansion specifically targets seniors (over 65) and individuals in long-term care facilities or receiving home and community-based services. The increased oversight aims to improve the safety and quality of healthcare provided to adult Medicaid recipients.

This bill expands the requirement for state Medicaid programs to monitor the use of antipsychotic medications. Starting January 1, 2024, this monitoring must cover all adult and senior Medicaid beneficiaries, including those in nursing homes and receiving home care services. The goal is to enhance safety and ensure the appropriate use of these powerful drugs for all eligible individuals, directly impacting healthcare quality.

Key points

Effective January 1, 2024, state Medicaid programs must monitor the use of antipsychotic medications for all beneficiaries, regardless of age.

This expansion specifically targets seniors (over 65) and individuals in long-term care facilities or receiving home and community-based services.

The increased oversight aims to improve the safety and quality of healthcare provided to adult Medicaid recipients.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.

Print number: HR 4096

Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]

Process start date: 2023-06-14

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-flash-latest

Source data: api.congress.gov

AI work logs for this document launch

Expanding Antipsychotic Drug Monitoring to All Medicaid Recipients.

Key Questions about Expanding Antipsychotic Drug Monitoring to All Medicaid Recipients.